Fibrocell Science Inc.
FCSC
FCSC was delisted on the 12th of December, 2019.
29 hedge funds and large institutions have $32.3M invested in Fibrocell Science Inc. in 2017 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 4 closing their positions.
100% more capital invested
Capital invested by funds: $16.1M → $32.3M (+$16.1M)
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
4% more funds holding
Funds holding: 28 → 29 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
13% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Creative Planning
Overland Park,
Kansas
|
+$120K |
| 2 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$86.4K |
| 3 |
Morgan Stanley
New York
|
+$70.2K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$53.2K |
| 5 |
Renaissance Technologies
New York
|
+$52.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$118K |
| 2 |
BlackRock
New York
|
-$67.1K |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$64K |
| 4 |
Goldman Sachs
New York
|
-$48K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$45.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
KF
26
Krilogy Financial
St. Louis,
Missouri
| $1K | -$827 | -67 | -67% |
|
27
JP Morgan Chase
New York
| $1K | +$494 | +40 | New |
|
|
AG
28
Advisor Group
Phoenix,
Arizona
| $1K | +$654 | +53 | New |
|
29
BNP Paribas Financial Markets
Paris,
France
| $8 | – | – | – |
|
|
30
Jacobs Levy Equity Management
Florham Park,
New Jersey
| – | -$64K | -6,448 | Closed |
|
|
31
Goldman Sachs
New York
| – | -$48K | -4,762 | Closed |
|
|
HVC
32
Healthcare Value Capital
Woodcliff Lake,
New Jersey
| – | -$39.3K | -3,185 | Closed |
|
|
ARTA
33
A.R.T. Advisors
New York
| – | -$21K | -2,121 | Closed |
|
FCSC Hedge Fund Activity: Q2 2017 in Review
29 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Fibrocell Science Inc. (FCSC) for Q2 2017, worth a combined $32.3M — up 100% from $16.1M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new FCSC positions and 4 closed out — a net gain of 1 holder — while 7 added to existing stakes and 8 trimmed.
The largest buyer was Creative Planning, adding an estimated $120K. The largest seller was Vanguard Group, cutting an estimated $118K.
- 29 institutional investors held Fibrocell Science Inc. (FCSC) as of Q2 2017, up from 28 in Q1 2017.
- Funds reported $32.3M of Fibrocell Science Inc. stock for Q2 2017, up 100% quarter-over-quarter.
- 5 funds opened new Fibrocell Science Inc. positions in Q2 2017 and 4 closed out, a net change of +1 holder.
- The largest Fibrocell Science Inc. buyer in Q2 2017 was Creative Planning, an estimated $120K added.
- The largest Fibrocell Science Inc. seller in Q2 2017 was Vanguard Group, an estimated $118K sold.
Based on aggregated 13F filings for Q2 2017.